Asian American Medical Group Limited announced that the company has determined to appoint new directors to the company's board, received commitments for the engagement of a new Managing Director and a new Executive Management team, and arranged $3.0 million in new funding, to position the Company for a reinvigoration of its existing medical services business, conditional upon the proposed resumption of trading of the company's shares on the ASX. Board and Executive Appointments: The following persons are to be appointed to the board of directors: Daniel Sims, Executive Chairman; Hamish Sprague, Executive Director; Angela Choong, Executive Director; Robert McKenzie, Non-Executive Director The company announced that Ms. Jeslyn Jacques Wee Kian Leong will resign as a non-executive director upon the appointment of the new directors at the company's reinstatement and the company takes this opportunity to thank Ms. Leong for her services as a Director. Mr. Ang Kong Meng and Mr. Evgenii Tugolukov remain on the board as non-executive directors.

Following these changes, the Board of AAMG will comprise on Reinstatement: Daniel Sims, Executive Chairman; Hamish Sprague, Executive Director; Angela Choong, Executive Director; Ang Kong Meng, Non-Executive Director, Evgenii Tugolukov, Non-Executive Director, Robert McKenzie, Non-Executive Director. The company also announced the following changes to its Executive Management team. Effective upon the Reinstatement, Ms. Angela Choong will become the company's chief operating officer.

In addition, the Company announced the appointment of leading Surgical Oncologist, C/Associate Professor Paul Moroz, as Director of Medical Services. The new Executive Management team of AAMG will comprise on Reinstatement: Hamish Sprague, Managing Director; Angela Choong, Chief Operating Officer; C/Associate Professor Paul Moroz, Director of Medical Services; Dario Nazzari, Company Secretary.